APA (7th ed.) Citation

L, F., C, B., KY, S., SR, P., C, M., AK, P., . . . P, W. (2024). A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. The British journal of dermatology, 190(2), 216. https://doi.org/10.1093/bjd/ljad397

Chicago Style (17th ed.) Citation

L, Fertitta, et al. "A Core Outcome Domain Set to Assess Cutaneous Neurofibromas Related to Neurofibromatosis Type 1 In clinical Trials." The British Journal of Dermatology 190, no. 2 (2024): 216. https://doi.org/10.1093/bjd/ljad397.

MLA (9th ed.) Citation

L, Fertitta, et al. "A Core Outcome Domain Set to Assess Cutaneous Neurofibromas Related to Neurofibromatosis Type 1 In clinical Trials." The British Journal of Dermatology, vol. 190, no. 2, 2024, p. 216, https://doi.org/10.1093/bjd/ljad397.